Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-015487

EVP, Chief Medical Officer acquired 22,013 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shah Jatin · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-25 Grant or award : show line 1 in the form +22,013 107,691 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-25 Grant or award : show line 2 in the form Stock Option (right to buy) +59,968 $14.56 2031-02-24 59,968 59,968 D
Loading xslF345X03/doc4.xml…